Conor continues to fly the flag for BioInnovate and used his time in the fellowship to cultivate an unmet need in Benign Prostatic Hyperplasia, which affects millions of men globally as they age. While awaiting investment from Enterprise Ireland’s Commercialisation Fund, Conor worked from June to October 2013 as an Investment Analyst/Advisor for Venture Capital firm Seroba Lifesciences. Upon award of an Enterprise Ireland grant, he became co-founder and CEO of ProVerum Medical until August 2017 and is now Chief Scientific Officer of the BioInnovate spin-out startup. He has won numerous awards and has received substantial Series A funding, which has facilitated the company to continue to develop Conor’s novel, universal solution for BPH.